Beranda › Gagal Jantung › Maryland
Uji klinis Gagal Jantung di Maryland
28 studi untuk Gagal Jantung mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Rockville
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Ascension Saint Agnes Heart Care, Baltimore
- Metropolitan Cardiovascular Consultants, Beltsville
- Capitol Cardiology Associates, Lanham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Ascension Saint Agnes Heart Care, Baltimore
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06424288Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Johns Hopkins University, Baltimore
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06517186A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Annapolis
- Research Site, Baltimore
- Research Site, Lanham
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University of Maryland Medical Center, Baltimore
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins University, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459Technical Development of Cardiovascular Magnetic Resonance Imaging
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04927429Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Baltimore
- Research Site, Beltsville
- Research Site, Lutherville-Timonium
- dan 1 lainnya
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Baltimore, MD Investigative Site 10101, Baltimore
- Bowie, MD Investigative Site 10020, Bowie
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Maryland Medical Center, Baltimore
- The Johns Hopkins Hospital, Baltimore
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06310031Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 7 hingga 100 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT03581318A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 106, Baltimore
Menerima pesertaFase 2
Usia 30 hingga 84 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07795814Rilonacept in Subjects With Cardiac Sarcoidosis
- Johns Hopkins University, Baltimore
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06660732Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Bethesda
- Hyattsville
- Salisbury
- dan 1 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- MedStar Health Research Institute, Baltimore
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Ascension Saint Agnes Heart Ca, Baltimore
- Mercy Medical Center, GI Research, Baltimore
- Flourish Research Bowie, Bowie
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001Alleviant ALLAY-HF Study
- Johns Hopkins Medical Institution, Baltimore
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05685303Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
- Johns Hopkins Center for Health Equity, Baltimore
- Johns Hopkins University Comstock Center, Hagerstown
Menerima peserta
Usia 30 hingga 70 · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06364644PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- MedStar, Baltimore
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Ascension Saint Agnes Heart Care, Baltimore
- Chesapeake Cardiac Care, Bowie
- Flourish Research - Bowie, Bowie
Menerima pesertaFase 2
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT06991257The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Johns Hopkins, Baltimore
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT03142152Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
- Johns Hopkins Medical Institutions, Baltimore
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Mar 2026 · NCT00181259Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
- Johns Hopkins University, Baltimore
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06932081Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
- University of Maryland Medical Center, Baltimore
- Johns Hopkins University School of Medicine, Baltimore
Menerima pesertaStudi observasional
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT00733590Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
- Johns Hopkins Hospital, Baltimore
Menerima pesertaStudi observasional
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 12 Jan 2026 · NCT06299436Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- Johns Hopkins University, Baltimore
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Feb 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- John Hopkins University School of Medicine, Baltimore
Menerima pesertaStudi observasional
Usia 14 hingga 65 · Semua jenis kelamin · Diperbarui 1 Nov 2024 · NCT06311708Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.